Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$5.06 - $10.78 $51,105 - $108,878
-10,100 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$5.64 - $23.33 $28,200 - $116,649
-5,000 Reduced 33.11%
10,100 $61,000
Q4 2020

Feb 12, 2021

BUY
$3.5 - $7.98 $52,850 - $120,498
15,100 New
15,100 $86,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.